NEW YORK (360Dx) – Ortho Clinical Diagnostics said today that it has entered an agreement with Sentinel Diagnostics for distribution and promotion of Sentinel's CRP Ultra (MP) wide-range C-reactive protein assay.
Ortho said that it will initially launch the assay, an immuno-turbidimetric test that measures CRP in serum or plasma, in North America, Europe, Africa, and the Middle East.
Financial and other terms of the agreement were not disclosed.